GSK set to invest £500m in its UK manufacturing sites

GSK is to invest more than £500m in the UK across its manufacturing sites to increase production of key active ingredients for its pharmaceutical products and vaccines. 

The company announced selection of Ulverston in Cumbria as the location for the first new GSK manufacturing facility to be built in the UK for almost 40 years. 

Investment will also be made at the company’s two manufacturing sites in Scotland at Montrose and Irvine. 

In total, it is anticipated these investments will create up to 1,000 new jobs over the lifetime of the projects, and will also benefit the wider construction industry and the many companies that supply GSK with services and facilities in the UK.